Visual outcomes after treatment in pediatric patients with Coats’ disease

Canadian Journal of Ophthalmology - Tập 54 - Trang 647-652 - 2019
Hannah H. Chiu1,2, Michael J. Wan1,2, Peter J. Kertes1,2,3, Rajeev H. Muni1,2,4, Wai-Ching Lam1,2,5
1Department of Ophthalmology and Vision Sciences, University of Toronto, Toronto, Ont.
2Department of Ophthalmology and Vision Sciences, The Hospital for Sick Children, Toronto, Ont
3The John and Liz Tory Eye Centre, Sunnybrook Health Sciences Centre, Toronto, Ont.
4Department of Ophthalmology, St. Michael's Hospital, Toronto, Ont.
5Department of Ophthalmology, The University of Hong Kong, Hong Kong

Tài liệu tham khảo

Shields, 2001, Classification and management of Coats disease: the 2000 Proctor Lecture, Am J Ophthalmol, 131, 572, 10.1016/S0002-9394(01)00896-0 Smithen, 2005, Coats’ disease diagnosed in adulthood, Ophthalmology, 112, 1072, 10.1016/j.ophtha.2004.12.038 Coats, 1908, Forms of retinal disease with massive exudation, Roy Lond Ophth Hosp Rep, 17, 440 Budning, 1998, Visual prognosis of Coats’ disease, J AAPOS, 2, 356, 10.1016/S1091-8531(98)90034-9 Schefler, 2008, Advanced Coats’ disease. Management with repetitive aggressive laser ablation therapy, Retina, 28, S38, 10.1097/IAE.0b013e318163cd7c Muftuoglu, 2011, Pars plana vitrectomy in advanced coats’ disease, Case Rep Ophthalmol, 2, 15, 10.1159/000323616 Ramasubramanian, 2012, Bevacizumab for Coats’ disease with exudative retinal detachment and risk of vitreoretinal traction, Br J Ophthalmol, 96, 356, 10.1136/bjophthalmol-2011-300141 Villegas, 2014, Advanced Coats’ disease treated with intravitreal bevacizumab combined with laser vascular ablation, Clin Ophthalmol, 8, 973 Gaillard, 2014, Ranibizumab in the management of advanced Coats disease Stages 3B and 4: long-term outcomes, Retina, 34, 2275, 10.1097/IAE.0000000000000248 Giannakopoulos, 2017, Intravitreal ranibizumab as an adjunctive treatment for Coats disease (6-year follow-up), Retin Cases Brief Rep, 11, 339, 10.1097/ICB.0000000000000363 1998, The ischemic optic neuropathy decompression trial (IONDT): design and methods, Control Clin Trials, 19, 276, 10.1016/S0197-2456(98)00003-8 Dunn, 1964, Multiple comparisons using rank sums, Technometrics, 6, 241, 10.1080/00401706.1964.10490181 Silodor, 1988, Natural history and management of advanced Coats’ disease, Ophthalmic Surg, 19, 89 Adam, 2007, Observations on the management of Coats’ disease: less is more, Br J Ophthalmol, 91, 303, 10.1136/bjo.2006.103382 Mrejen, 2008, Management of retinal detachment in Coats disease. Study of 15 cases, Retina, 28, S26, 10.1097/IAE.0b013e31816b3158 Rishi, 2010, Coats’ disease: an Indian perspective, Indian J Ophthalmol, 58, 119, 10.4103/0301-4738.60081 Ong, 2017, Comparison of visual outcomes in Coats’ disease: a 20-year experience, Ophthalmology, 124, 1368, 10.1016/j.ophtha.2017.03.051 Shields, 2001, Differentiation of coats’ disease and retinoblastoma, J Pediatr Ophthalmol Strabismus, 38, 262, 10.3928/0191-3913-20010901-05 Kiratli, 1998, Management of moderate to advanced Coats’ disease, Ophthalmologica, 212, 19, 10.1159/000027253 Shields, 2006, Retinoblastoma in an eye with features of Coats’ disease, J Pediatr Ophthalmol Strabismus, 43, 313, 10.3928/01913913-20060901-08 Shen, 2015, Pars plana vitrectomy and evisceration resulting in death due to misdiagnosis of retinoblastoma in children: a review of 3 cases, Medicine (Baltimore), 94, e1338, 10.1097/MD.0000000000001338 Soliman, 2017, Retinoblastoma versus advanced Coats’ disease: is enucleation the answer?, Ophthalmic Genet, 38, 291, 10.1080/13816810.2016.1199715